Colleen F. Hanrahan

Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

Hua Zhong, Kelly A. Chiles, David M. Feldser et al. · PubMed · 2000 · 1.5K citations

Cancer Biology, Tumor Biology, Tumor Angiogenesis +17

Levels of Hypoxia-Inducible Factor-1  During Breast Carcinogenesis

Reinhard Bos, Haining Zhong, Colleen F. Hanrahan et al. · JNCI Journal of the National Cancer Institute · 2001 · 588 citations · Full text

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines

Marina Protopopova, Colleen F. Hanrahan, B. V. Nikonenko et al. · Journal of Antimicrobial Chemotherapy · 2005 · 371 citations · Full text

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug

Lee Jia, Joseph E. Tomaszewski, Colleen F. Hanrahan et al. · British Journal of Pharmacology · 2004 · 235 citations · Full text

Pharmaceutical Science, High-throughput Combinatorial Screening, Tuberculosis Prevention +18

Angiogenesis and prostate cancer: identification of a molecular progression switch.

Wendy J. Huss, Colleen F. Hanrahan, Roberto Barrios et al. · PubMed · 2001 · 234 citations

Pathology, Cancer Biology, Tumor Biology +18